CIMdata PLM Industry Summary Online Archive

21 May 2007

Implementation Investments

Arrhythmia Research Technology Chooses IFS Applications to Accommodate Diversifying Business

IFS announced that Arrhythmia Research Technology Inc . of Fitchburg, Mass. has selected and will implement IFS Applications at its headquarters and subsidiaries. Working with Corning Data Services of Corning, N.Y., Arrhythmia Research Technology has purchased the entire suite of IFS Applications.

Arrythmia Research Technology is growing by acquisition and diversification, and needed an enterprise application that would not only help them comply with Sarbanes-Oxley and FDA regulations for medical device manufacturers, but accommodate mixed manufacturing modes, including repetitive, make-to-stock and engineer-to-order.

"IFS Applications will allow us to support our operations in the long run as we explore new business opportunities in a number of verticals," Arrhythmia Director of Information Technology Salvatore Emma said. "Our primary products have been silver / silver chloride and conductive carbon sensors for use in heart monitoring and bioinstrumentation electrodes."

According to Emma, the company's already-dominant share in the ECG sensor market has driven Arrhythmia Research Technology to diversify its business model. The company required a flexible, powerful enterprise application that could provide real-time views of multiple business units and adapt quickly to accommodate new opportunities in the future.

"Recently, we have been expanding our custom thermal plastic injection molding business -- making a variety of thermoplastic injection molded products and assemblies for medical, consumer, electronic and defense markets," Emma said. "We are also manufacturing medical device components and other specialized metal products that are outside our primary bioinstrumentation electrode market."

According to IFS North America President and CEO Cindy Jaudon, the situation faced by Arrhythmia Research Technology is typical of many other middle-market companies.

"To grow a business in the 21st Century, you need to mobilize resources quickly when opportunities present themselves," Jaudon said. "This is exactly the type of agility IFS Applications and its component-based service oriented architecture (SOA) delivers to our customers. As your business changes, IFS Applications can be reconfigured and augmented to meet your needs with minimal business disruption. Arrhythmia Research Technology has seen their operation change quite a bit already as they position themselves for growth, and their instance of IFS Applications will grow and change with them even more as they identify new opportunities in the market."

Real-time visibility of the company's various divisions was also a priority in selecting IFS Applications, according to Emma.

"Today we have many disparate systems across our enterprise," Emma said. "As a result, it takes a long time to analyze the results of our operations. With the real-time reporting capabilities of IFS Applications, we can turn these data islands into knowledge that is timely, meaningful and accurate."

Become a member of the CIMdata PLM Community to receive your daily PLM news and much more.

Tell us what you think of the CIMdata Newsletter. Send your feedback.

CIMdata is committed to your privacy. Your personal information will never be sold or shared outside of CIMdata without your express permission.

Subscribe